Cargando…

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides

Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Daralnakhla, Haneen, Saher, Osama, Zamolo, Susanna, Bazaz, Safa, P. Bost, Jeremy, Heitz, Marc, Lundin, Karin E., EL Andaloussi, Samir, Darbre, Tamis, Reymond, Jean-Louis, Zain, Rula, Smith, C. I. Edvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831936/
https://www.ncbi.nlm.nih.gov/pubmed/33477663
http://dx.doi.org/10.3390/pharmaceutics13010116
_version_ 1783641725933191168
author Daralnakhla, Haneen
Saher, Osama
Zamolo, Susanna
Bazaz, Safa
P. Bost, Jeremy
Heitz, Marc
Lundin, Karin E.
EL Andaloussi, Samir
Darbre, Tamis
Reymond, Jean-Louis
Zain, Rula
Smith, C. I. Edvard
author_facet Daralnakhla, Haneen
Saher, Osama
Zamolo, Susanna
Bazaz, Safa
P. Bost, Jeremy
Heitz, Marc
Lundin, Karin E.
EL Andaloussi, Samir
Darbre, Tamis
Reymond, Jean-Louis
Zain, Rula
Smith, C. I. Edvard
author_sort Daralnakhla, Haneen
collection PubMed
description Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acid peptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreated HeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)(4) (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs.
format Online
Article
Text
id pubmed-7831936
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78319362021-01-26 Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides Daralnakhla, Haneen Saher, Osama Zamolo, Susanna Bazaz, Safa P. Bost, Jeremy Heitz, Marc Lundin, Karin E. EL Andaloussi, Samir Darbre, Tamis Reymond, Jean-Louis Zain, Rula Smith, C. I. Edvard Pharmaceutics Article Non-viral transfection reagents are continuously being developed in attempt to replace viral vectors. Among those non-viral vectors, dendrimers have gained increasing interest due to their unique molecular structure and multivalency. However, more improvements are still needed to achieve higher efficacy and lower toxicity. In this study, we have examined 18 peptide dendrimers conjugated to lipophilic moieties, such as fatty acids or hydrophobic amino acids, that were previously explored for siRNA. Reporter cells were employed to investigate the transfection of single strand splice-switching oligonucleotides (ONs) using these peptide dendrimers. Luciferase level changes reflecting efficiency varied with amino acid composition, stereochemistry, and complexation media used. 3rd generation peptide dendrimers with D-amino acid configuration were superior to L-form. Lead formulations with 3rd generation, D-amino acid peptide dendrimers increased the correction level of the delivered ON up to 93-fold over untreated HeLa Luc/705 cells with minimal toxicity. To stabilize the formed complexes, Polyvinyl alcohol 18 (PVA18) polymer was added. Although PVA18 addition increased activity, toxicity when using our best candidates G 2,3KL-(Leu)(4) (D) and G 2,3KL-diPalmitamide (D) was observed. Our findings demonstrate the potential of lipid-conjugated, D-amino acid-containing peptide dendrimers to be utilized as an effective and safe delivery vector for splice-switching ONs. MDPI 2021-01-18 /pmc/articles/PMC7831936/ /pubmed/33477663 http://dx.doi.org/10.3390/pharmaceutics13010116 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Daralnakhla, Haneen
Saher, Osama
Zamolo, Susanna
Bazaz, Safa
P. Bost, Jeremy
Heitz, Marc
Lundin, Karin E.
EL Andaloussi, Samir
Darbre, Tamis
Reymond, Jean-Louis
Zain, Rula
Smith, C. I. Edvard
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title_full Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title_fullStr Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title_full_unstemmed Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title_short Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
title_sort lipophilic peptide dendrimers for delivery of splice-switching oligonucleotides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831936/
https://www.ncbi.nlm.nih.gov/pubmed/33477663
http://dx.doi.org/10.3390/pharmaceutics13010116
work_keys_str_mv AT daralnakhlahaneen lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT saherosama lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT zamolosusanna lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT bazazsafa lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT pbostjeremy lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT heitzmarc lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT lundinkarine lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT elandaloussisamir lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT darbretamis lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT reymondjeanlouis lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT zainrula lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides
AT smithciedvard lipophilicpeptidedendrimersfordeliveryofspliceswitchingoligonucleotides